CN Patent

CN112543757A — 对结核菌具有抗菌活性的缩合氮杂杂芳基化合物

Assigned to Zydus Lifesciences Ltd · Expires 2021-03-23 · 5y expired

What this patent protects

本发明涉及可用于治疗细菌感染的新的通式(I)化合物、其对映体、其非对映体、其可药用盐、或其前药。通式(I)化合物表现出DprE1酶抑制活性。

USPTO Abstract

本发明涉及可用于治疗细菌感染的新的通式(I)化合物、其对映体、其非对映体、其可药用盐、或其前药。通式(I)化合物表现出DprE1酶抑制活性。

Drugs covered by this patent

Patent Metadata

Patent number
CN112543757A
Jurisdiction
CN
Classification
—
Expires
2021-03-23
Drug substance claim
No
Drug product claim
No
Assignee
Zydus Lifesciences Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.